ID
28249
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Study part: Demographics (Screening) Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (4)
- 25/11/17 25/11/17 -
- 30/11/17 30/11/17 -
- 31/12/17 31/12/17 -
- 20/9/21 20/9/21 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
31 de diciembre de 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Screening Demographics GOAL Trial B-cell Lymphoma NCT02499003
Screening Demographics GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Screening Demographics GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)